Carl H. Rose
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Carl H. Rose has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Brian Charles Brost
Department of Obstetrics and Gynecology, Wake Forest University School of Medicine, Winston-Salem, NC
7 shared publications - Katherine W. Arendt
Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA
3 shared publications - Anitha S. John
Division of Cardiology, Children’s National Hospital, Washington, USA
2 shared publications Arij Faksh
Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55902
2 shared publications- Ashley Park
Laboratory of Applied Precision Omics, National Heart, Lung, and Blood Institute (A.P., T.E.A., M.K., H.K., W.P., M.J., S.A.-E.), National Institutes of Health, Bethesda, MD
2 shared publications - Daniel Cabrera
Centro de Investigación e Innovación Biomédica, Facultad de Medicina, Universidad de los Andes, Santiago 7620001, Chile
2 shared publications
Latest Publications
- 27 August 2026
- Published by Springer Nature in Current Cardiovascular Risk Reports
- Vol. 20 (1) , 6
Pregnancy-Associated Myocardial Infarction: Mechanisms, Diagnosis, Management, and Postpartum Risk
- 27 August 2026
- Published by Springer Nature in Current Cardiovascular Risk Reports
- Vol. 20 (1) , 6
Pregnancy-Associated Myocardial Infarction: Mechanisms, Diagnosis, Management, and Postpartum Risk
- 6 August 2024
- Published by Springer Nature
- p. 2843-2863
Management of the Pregnant Woman with Congenital Heart Disease
- 6 August 2024
- Published by Springer Nature
- p. 2843-2863
Management of the Pregnant Woman with Congenital Heart Disease
- 13 August 2023
- Published by Springer Nature
- p. 1-21
Management of the Pregnant Woman with Congenital Heart Disease
- 13 August 2023
- Published by Springer Nature
- p. 1-21
Management of the Pregnant Woman with Congenital Heart Disease
- 6 May 2022
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 36 (9) , 3685-3686
Maternal and Fetal Outcomes in Women with Congenital Heart Disease
- 6 May 2022
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 36 (9) , 3685-3686
Maternal and Fetal Outcomes in Women with Congenital Heart Disease
- 1 July 2021
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 3 (4) , 100373
Timing of delivery with coronavirus disease 2019 pneumonia requiring intensive care unit admission
- 1 July 2021
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 3 (4) , 100373
Timing of delivery with coronavirus disease 2019 pneumonia requiring intensive care unit admission
- 22 December 2020
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 137 (3) , 431-433
Acute Pancreatitis in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19)
BACKGROUND: Pregnant women with coronavirus disease 2019 (COVID-19) infection are at risk for a variety of COVID-19 complications. CASE: We report a case of acute pancreatitis in a pregnant patient hospitalized for COVID-19 pneumonia. Comprehensive evaluation ruled out other etiologies of acute pancreatitis. Preterm labor developed at 33 5/7 weeks of gestation, and the patient delivered a liveborn male neonate; neonatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) screening was negative. The patient improved significantly postpartum and was discharged home on postpartum day 3. CONCLUSION: Coronavirus disease 2019 may present in pregnancy with a myriad of clinical symptoms other than respiratory. Acute pancreatitis represents an infrequent complication of primary COVID-19 infection.
- 22 December 2020
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 137 (3) , 431-433
Acute Pancreatitis in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19)
BACKGROUND: Pregnant women with coronavirus disease 2019 (COVID-19) infection are at risk for a variety of COVID-19 complications. CASE: We report a case of acute pancreatitis in a pregnant patient hospitalized for COVID-19 pneumonia. Comprehensive evaluation ruled out other etiologies of acute pancreatitis. Preterm labor developed at 33 5/7 weeks of gestation, and the patient delivered a liveborn male neonate; neonatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) screening was negative. The patient improved significantly postpartum and was discharged home on postpartum day 3. CONCLUSION: Coronavirus disease 2019 may present in pregnancy with a myriad of clinical symptoms other than respiratory. Acute pancreatitis represents an infrequent complication of primary COVID-19 infection.
- 1 July 2016
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 215 (1) , 131
Reply
- 1 July 2016
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 215 (1) , 131
Reply
- 11 April 2016
- Published by Taylor & Francis in Hypertension in Pregnancy
- Vol. 35 (3) , 394-404
Preeclampsia/Eclampsia candidate genes show altered methylation in maternal leukocytes of preeclamptic women at the time of delivery
Objective: To analyze methylation profiles of known preeclampsia/eclampsia (PE) candidate genes in normal (NL) and preeclamptic (PE) women at delivery. Methods: A matched case–control study comparing methylation in 79 CpG sites/33 genes from an independent gene set in maternal leukocyte DNA in PE and NL (n = 14 each) on an Illumina BeadChip platform. Replication performed on second cohort (PE = 12; NL = 32). Results: PE demonstrates differential methylation in POMC, AGT, CALCA, and DDAH1 compared with NL. Conclusion: Differential methylation in four genes associated with PE may represent a potential biomarker or an epigenetic pathophysiologic mechanism altering gene transcription.
- 11 April 2016
- Published by Taylor & Francis in Hypertension in Pregnancy
- Vol. 35 (3) , 394-404
Preeclampsia/Eclampsia candidate genes show altered methylation in maternal leukocytes of preeclamptic women at the time of delivery
Objective: To analyze methylation profiles of known preeclampsia/eclampsia (PE) candidate genes in normal (NL) and preeclamptic (PE) women at delivery. Methods: A matched case–control study comparing methylation in 79 CpG sites/33 genes from an independent gene set in maternal leukocyte DNA in PE and NL (n = 14 each) on an Illumina BeadChip platform. Replication performed on second cohort (PE = 12; NL = 32). Results: PE demonstrates differential methylation in POMC, AGT, CALCA, and DDAH1 compared with NL. Conclusion: Differential methylation in four genes associated with PE may represent a potential biomarker or an epigenetic pathophysiologic mechanism altering gene transcription.
- 1 November 2015
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 213 (5) , 653-653.e1
Challenging the 4- to 5-minute rule: from perimortem cesarean to resuscitative hysterotomy
- 1 November 2015
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 213 (5) , 653-653.e1
Challenging the 4- to 5-minute rule: from perimortem cesarean to resuscitative hysterotomy
- 1 March 2015
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 125 (3) , 732-734
Factitious Disorder-by-Proxy Simulating Fetal Growth Restriction
BACKGROUND: Although a variety of presentations have been described in the literature, the true prevalence of factitious disorder, also commonly known as Munchausen syndrome, and factitious disorder-by-proxy in pregnancy is unknown. The authors present a unique case in which intrauterine fetal growth restriction was simulated through fabrication of prenatal records. CASE: A 30-year-old woman, gravida 6 para 3113, was transferred at 38 4/7 weeks of gestation for severe fetal growth restriction. The clinic listed in the patient-provided prenatal record was contacted to obtain original ultrasonographic reports for verification of gestational age; however, further investigation revealed the patient had never attended this clinic nor was the ostensible treating physician ever employed there. The initial prenatal record subsequently was determined to be entirely fabricated. CONCLUSION: In this era of extensive technologic resources, health care providers should consider the possibility of factitious disorder when patient-provided medical record-derived information is inconsistent with the clinical presentation.
- 1 March 2015
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 125 (3) , 732-734
Factitious Disorder-by-Proxy Simulating Fetal Growth Restriction
BACKGROUND: Although a variety of presentations have been described in the literature, the true prevalence of factitious disorder, also commonly known as Munchausen syndrome, and factitious disorder-by-proxy in pregnancy is unknown. The authors present a unique case in which intrauterine fetal growth restriction was simulated through fabrication of prenatal records. CASE: A 30-year-old woman, gravida 6 para 3113, was transferred at 38 4/7 weeks of gestation for severe fetal growth restriction. The clinic listed in the patient-provided prenatal record was contacted to obtain original ultrasonographic reports for verification of gestational age; however, further investigation revealed the patient had never attended this clinic nor was the ostensible treating physician ever employed there. The initial prenatal record subsequently was determined to be entirely fabricated. CONCLUSION: In this era of extensive technologic resources, health care providers should consider the possibility of factitious disorder when patient-provided medical record-derived information is inconsistent with the clinical presentation.